Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €339.10 | €369.72 | 9.031% |
| Molina Healthcare | 12 | 1 | 1 | 0 | €315.60 | €366.73 | 16.200% |
| Icon plc | 18 | 0 | 4 | 0 | €280.90 | €319.67 | 13.802% |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.60 | €228.30 | 61.229% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €162.10 | €215.54 | 32.966% |
| Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €102.25 | €184.92 | 80.851% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.05 | €147.62 | 16.187% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Davita Inc. | 2 | 0 | 0 | 0 | €124.95 | €124.89 | -0.050% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €92.00 | €124.85 | 35.704% |
| Tenet Healthcare | 28 | 0 | 7 | 0 | €112.00 | €121.67 | 8.631% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €109.00 | €116.50 | 6.877% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €102.10 | €110.00 | 7.738% |
| CONMED Corp. | 11 | 1 | 3 | 0 | €65.00 | €109.59 | 68.592% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €86.50 | €97.90 | 13.182% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €84.50 | €92.26 | 9.183% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €73.00 | €86.90 | 19.037% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €65.08 | €85.68 | 31.660% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €39.80 | €84.74 | 112.925% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €72.50 | €79.00 | 8.966% |